CMS advised Prof. Viktor Meineke on the deal. The founder of the DermaZentrum Group, Prof. Viktor Meineke, has sold a majority stake in the group to...
You must be a Standard 1 Year member to access this content.
IN BRIEF: CMS Hasche Sigle, advised on the matter. CMS Hasche Sigle advised Viktor Meineke with a team including Christoph L?hler (Picture – Corporate M&A), Roland...
You must be a Standard 1 Year member to access this content.
CMS advised Bruker on the deal. PreOmics GmbH, which is headquartered in Martinsried near Munich, has raised EUR 13.5 million in a Series B round of...
You must be a Standard 1 Year member to access this content.
IN BRIEF: CMS Hasche Sigle, advised on the matter. CMS Hasche Sigle advised Bruker Corporation with a team including Philippe Heinzke (IP&IT), Hendrik Hirsch (Picture –...
You must be a Standard 1 Year member to access this content.
King & Wood Mallesons, Ehlers & Partner and Shearman & Sterling assisted the Investor consortium on the acquisition. CMS advised the Regneri family as the sellers....
You must be a Standard 1 Year member to access this content.
CMS advised Harald Quandt Industriebeteiligungen GmbH on the deal. Harald Quandt Industriebeteiligungen GmbH (HQIB) has acquired a majority shareholding in Funke Medical AG, the market leader...
You must be a Standard 1 Year member to access this content.
IN BRIEF: CMS Hasche Sigle, advised on the matter. CMS Hasche Sigle advised Harald Quandt Industriebeteiligungen GmbH with a team including Hendrik Hirsch (Picture – Corporate...
You must be a Standard 1 Year member to access this content.
CMS advised Atos Medical on the deal. Atos Medical, a global leader in laryngectomy care, has acquired the Tracoe Group and UK-based Kapitex Healthcare. Tracoe includes...
You must be a Standard 1 Year member to access this content.
CMS advised Uniphar on the deal. Poellath advised CoRRect Medical GmbH. Uniphar Europe Limited, a subsidiary of publicly-listed Uniphar PLC, based in Dublin, has acquired CoRRect...
You must be a Standard 1 Year member to access this content.
CMS advised Discovery Life Sciences on the deal. Büsing Müffelmann & Theye advised the shareholders of Targos Molecular Pathology . The US-American biosample and biomarker specialist...
You must be a Standard 1 Year member to access this content.
